Abstract
Purpose of Review
In this article we describe the utility, indications, contraindications, limitations, and clinical situations in which transesophageal echocardiography (TEE) examination can be instrumental in managing patients in the intensive care unit (ICU).
Recent Findings
TEE is a safe and semi-invasive diagnostic modality that can be used to differentiate pathologies, determine hemodynamic status, guide management, and determine response to therapy. Its presence has expanded beyond the operating rooms into the critical care world. Despite limited randomized trials, evidence indicates its significant benefits and potential for early diagnosis to reduce morbidity and mortality.
Summary
Patients in the ICU present with multifactorial form of shock, hypoxemia needing monitoring and mechanical circulatory support. TEE is a low-risk diagnostic and monitoring tool which is invaluable in the ICU. Its advantages include superior visualization of cardiac structures and accurate assessment of abnormalities. Judicious utilization of TEE holds the potential to significantly influence clinical decision-making in a favorable manner.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Patients admitted to critical care units invariably present with a diverse array of systemic pathologies, necessitating intricate and judicious management strategies. These critically ill patients need a variety of monitoring and diagnostic modalities. Within this context, echocardiography has emerged as an indispensable modality, assuming a vital role in clinical practice [1, 2••] diagnosis and management of structural heart disease, differentiating etiology of shock and hypoxemia, assisting with placement of mechanical support devices and guiding the management of critically ill patients [3]
TEE offers superior diagnostic capability when transthoracic echocardiographic (TTE) images may be inadequate. Examples include patients with wounds or surgical dressings over the chest and abdomen, patients who are placed in the prone position on mechanical ventilation, or those who are obese. TEE also carries a diagnostic advantage during advanced cardiac life support as it can guide resuscitation during ongoing chest compressions and for continued assessment and to place mechanical circulatory support (MCS) devices if indicated. A survey of the literature underscores the transformative potential of TEE, manifesting in novel diagnoses in 27% to 98% of cases and precipitating substantive alterations in treatment paradigms in up to 80% of instances. [3,4,5].
Indications
In a critical care setting, TEE is an invaluable diagnostic tool in a myriad of scenarios. These include instances of unexplained hemodynamic instability, hypoxemia, cardiorespiratory arrest, post-cardiac surgery complications, tamponade (Fig. 1), suspected pulmonary emboli, the suspected thoracic aortic dissection, trauma cases involving the cardiovascular system and shock, endocarditis, and identification of cardiac or aortic sources of embolism [2••, 5, 6]. TEE plays a crucial role in assessing volume status and in titrating fluids, vasopressors, and inotropes. It is also used to guide the placement and confirm the positioning of central venous lines, pulmonary artery catheters, and MCS devices. TEE serves to guide the insertion of extracorporeal membrane oxygenation (ECMO) cannulas, monitor hemodynamics on ECMO, guide management decisions, and facilitate weaning from MCS devices [6]. Additionally, TEE is instrumental in differentiating the causes of hypoxemia, such as identifying cardiac etiologies, intracardiac or intrapulmonary shunts, congestion, and the presence of pleural effusion. It also plays a crucial role in ruling out the cardiac source of embolism in patients with stroke or transient ischemic attack, and in confirming the absence of a left atrial appendage (LAA) clot before cardioversion [3, 5,6,7].
Contraindications
While complications associated with TEE are infrequent, instances of mechanical and esophageal injuries have been documented. Thorough evaluation and exclusion of esophageal and gastric pathologies are imperative before performing a TEE. Absolute contraindications encompass a spectrum of conditions, including esophageal perforation, strictures, tumors, tears, diverticuli, active upper gastrointestinal (GI) bleeding, previous esophageal surgeries, and recent upper GI surgery or intervention [3, 6, 8].
Relative contraindications include unstable atlantoaxial joint disease, severe symptomatic cervical arthritis, symptomatic hiatal hernia, recent upper GI bleeding, peptic ulcer disease, large abdominal aortic aneurysm, Barrett's esophagus, and coagulopathies [3, 6, 8].
Safety
The semi-invasive nature of TEE mandates consideration of potential complications stemming from the blind insertion and manipulation of the ultrasound probe. These complications may encompass oropharyngeal issues such as lip bruising, dental injury, or laryngeal perforation [3, 5, 9]. Esophageal implications may involve odynophagia, dysphagia, and the risk of Mallory-Weiss tears, while gastric trauma is also a conceivable adverse outcome [10, 11]. Furthermore, more severe complications such as splenic laceration, compression of mediastinal structures, airway compromise, thermal injury, burns, and even tongue necrosis may occur. While it is imperative to recognize these potential complications associated with TEE probe placement and manipulation, it is crucial to underscore their rarity [6].
Limitations to Use
TEE-derived information should be integrated with the clinical examination, invasive hemodynamic monitoring, biomarkers of hypoperfusion, and so on. Limitations include misconceptions of easy mastery of technique, technical errors such as image exclusion, and interpretive omissions and misinterpretation. In addition to being semi-invasive, TEE is less repeatable when compared to TTE, requires training and competence, involves a high fixed cost of equipment, and provides intermittent data [3, 6, 12•, 13].
TEE for Hemodynamic Assessment and Evaluation
The integration of TEE examination with invasive measurements of systemic arterial and venous pressures and biomarkers of tissue perfusion can facilitate functional hemodynamic monitoring [14,15,16]. This integrated approach proves instrumental in providing a comprehensive assessment of the circulatory system, optimizing tissue perfusion and assessing heart–lung interactions. The amalgamation of TEE data with invasive measurements allows for the differentiation of shock etiologies, identification of multiple shock states, and valuable insights such as fluid responsiveness, fluid tolerance, myocardial dysfunction, risk or presence of congestion, dynamic left ventricular obstruction, and other acute conditions that contribute to life-threatening hemodynamic instability, such as pulmonary embolism and aortic dissection (Refer to Figs. 2 and 3).
Preload Assessment
TEE is invaluable in assessing preload in critically ill patients, offering both qualitative and quantitative insights. A hyperdynamic left ventricle (LV) may indicate low filling pressures, while specific observations like kissing papillary muscles or LV end-systolic cavity obliteration may suggest hypovolemia progressing to shock. Care must be taken to avoid foreshortened views and assess the position of the interventricular septum (IVS) and right ventricular (RV) function. Additionally, respiratory variations in velocity time integral (VTI) at the left ventricular outflow tract (LVOT) can help evaluate stroke volume and fluid responsiveness [7, 18, 19].
TEE facilitates the assessment of volume responsiveness by examining LV chamber size and function before and after fluid bolus administration [20]. It allows evaluation of both static predictors like estimated filling pressures and dynamic predictors like variations in the LVOT velocity time integral (LVOT-VTI). Additional indicators, such as changes in left ventricular end-diastolic area (LVEDA) in the trans-gastric mid-papillary short-axis (SAX) view with fluid bolus or passive leg raise, enhance the evaluation. This comprehensive approach, combined with invasive monitoring and perfusion biomarkers, guides clinicians in effective management and indicates resuscitation adequacy.
Measurement of LVOT-VTI
The LVOT-VTI can be acquired using the trans-gastric long-axis (LAX) or deep trans-gastric five-chamber view, providing insights into LVOT flow dynamics and quantifying the blood volume ejected through the LVOT with each heartbeat. This parameter aids in measuring cardiac output and differentiating causes of hypotension, particularly in identifying hypovolemia, assessing fluid responsiveness, and detecting dynamic LVOT obstruction with a dagger-shaped profile [18, 19].
In mechanically ventilated patients, measurements are typically taken at end-expiration or during apnea. LVOT diameter measured in mid-systole using the mid-esophageal aortic valve LAX view, preferably with a zoomed image for accuracy. VTI assessment with Doppler should be made at the same site where LVOT diameter is measured.
Normal LVOT cross-sectional area ranges from 3 to 5 cm2, with stroke volume between 60 and 75 mL. The normal LVOT-VTI falls within 15 to 20 cm. Assumptions include treating the LVOT as circular when it is oval, and limitations involve potential underestimation with an off-axis Doppler and overestimation when the Doppler is closer to the aortic valve (AV). Multiple VTI measurements should be averaged to accommodate fluctuations in stroke volume (SV) due to conditions such as atrial fibrillation, hypovolemia, or tamponade.
TEE Views for Assessment of Hemodynamics and Shock
A systematically performed TEE assessment stands as an indispensable tool for the comprehensive evaluation of hemodynamic states [21]. Shock is one of the most common causes for ICU admission. Basic knowledge of TEE views is essential when making a clinical inference [5] (Refer to Table 1).
TEE as Pulmonary Artery Catheter
Pulmonary artery catheterization (PAC) can provide useful information about systemic hemodynamics and heart–lung interactions. However, in patients who do not have a PAC, TEE can be used to estimate chamber pressures using Doppler principles. RA pressure or central venous pressure (RAP/ CVP) can be estimated using size and distensibility of the IVC. Right ventricular systolic pressure (RVSP) can be estimated based on Doppler assessment of tricuspid valve regurgitation (TR) jet which then should correlate with PA systolic pressure (PASP) if there is no RVOT obstruction or pulmonic valve stenosis [24]. PA systolic pressures and Doppler assessment of pulmonic valve insufficiency jet can be used to assess PA systolic and diastolic pressures as seen in Table 2.
Additionally, TEE can be used to estimate left atrial pressure (LAP) and LV end-diastolic pressures (LVEDP) if there are MR or aortic regurgitation (AR) jets present respectively [7].
TEE facilitates the measurement of cardiac output (CO) and stroke volume (SV). These measurements can be obtained at various locations, including the AV, LVOT, and RVOT. However, the LVOT is commonly chosen for such assessments using the following formulas.
Cardiac Output (CO):
Stroke Volume (SV):
Rescue TEE for Hemodynamic Instability [25]
In the ICU, a systematic TEE examination can play a pivotal role in establishing a rapid and accurate diagnosis. As a dynamic, real-time monitoring tool, echocardiography serves as a linchpin at the patient's bedside, affording insights into the dynamic fluctuations of cardiorespiratory status and valuable hemodynamic assessment of patients presenting with shock states and hemodynamic instability [5, 26] (Refer to Fig. 4). It is imperative to correlate echocardiographic findings with the clinical context to ensure a precise diagnosis [2••]. Several conditions contribute to hemodynamic instability, broadly categorized as follows:
-
Obstructive Shock:
-
Cardiac Tamponade: TEE examination will reveal the presence of pericardial effusion and tamponade physiology (Refer to Fig. 1). TEE can be used to guide bedside pericardiocentesis.
-
Pulmonary Embolism: Signs include acute RV strain, septal deviation towards the left, and evidence of RV overload (Refer to Fig. 3). Other causes include patient-ventilator dyssynchrony, auto-positive end-expiratory pressure (auto-PEEP) and tension pneumothorax.
-
-
Distributive Shock:
-
Arises from vasodilation and low systemic vascular resistance (SVR), and is seen in conditions such as sepsis, anaphylaxis, inflammatory responses, vasoplegia post-cardiopulmonary bypass, and liver failure. May present in isolation or in combination with other shock pathologies.
-
Echocardiography will show collapsible IVC, SVC, LV hypercontractile with preserved or higher ejection fraction. LVOT-VTI will have respiratory variations.
-
-
Hypovolemic Shock:
-
Relative or absolute hypovolemia or bleeding, presenting with a small and collapsible IVC, decreased LVEDA, reduced LVOT-VTI, and low cardiac output.
-
Both Hypovolemia and Low Afterload: TEE enables qualitative and quantitative assessment of preload, aiding in the differentiation between hypovolemia and low afterload. Both conditions may appear hyperdynamic with decreased end-systolic diameter. Differentiation is achieved through LVEDA measurement—normal with low SVR and reduced with hypovolemia. LVOT-VTI/cardiac output measurements help assess if cardiac output is decreased or high [18, 19].
-
-
Cardiogenic shock:
-
Cardiogenic shock is defined as the heart's inability to maintain adequate tissue perfusion to meet metabolic demands [27, 28]. It is common in critically ill patients and is associated with high mortality rates. Rapid recognition, determination of underlying causes, and assessment of hemodynamic status are vital for effective management. Echocardiography serves as a cornerstone in the evaluation and management of cardiogenic shock due to its ability to provide real-time, non-invasive assessment of cardiac structure and function.
-
Cardiogenic shock can arise from various conditions such as myocardial ischemia, infarction, mechanical complications of infarction like acute mitral insufficiency, ventricular septal rupture, valvular heart diseases like aortic stenosis, mitral stenosis, mitral regurgitation, decompensated heart failure (either systolic or diastolic), arrhythmias, dynamic LVOT obstruction, pulmonary embolism, or biventricular dysfunction. Diagnosis of cardiogenic shock on TEE involves qualitative and quantitative assessment with multiple TEE views. Cardiogenic shock will typically present with reduced ejection fraction, reduced cardiac output calculated from LVOT-VTI, likely dilated IVC, presence of ischemia presenting with RWMA, and gross valvular abnormalities or infective endocarditis which can be evaluated by TEE. Cardiogenic shock may be due to isolated left or right ventricular failure or biventricular failure.
-
Left Ventricular Dysfunction
Differential diagnoses include acute coronary syndrome, sepsis-induced cardiomyopathy, stress cardiomyopathy (Takotsubo), myocarditis, toxin-induced cardiomyopathy, etc. Ischemia will present with RWMA in respective coronary artery distribution (Refer to Fig. 5). RWMA is assessed through various TEE views, such as ME 4-chamber, 2-chamber, LAX, and transgastric midpapillary SAX. The global LV function can be measured by Simpson's or 3D ejection fraction assessment. Consideration of the impact of inotropic support on measurements is essential. Nonischemic conditions that may mimic RWMA include bundle branch blocks, external pacing, and stress-induced cardiomyopathy. TEE can evaluate mechanical complications following myocardial infarction, such as chordal or papillary muscle rupture. The posteromedial papillary muscle is more prone to rupture due to a single blood supply. Other complications, such as post-myocardial infarction, ventricular septal rupture, and LV free wall rupture, can be diagnosed by TEE. TEE can evaluate for the presence of valvular heart disease and grade severity like mitral stenosis and regurgitation, aortic stenosis, and regurgitation. It can also quantify the LV dysfunction associated with valvular heart disease. TEE can evaluate diastolic dysfunction and guide fluid management in patients with LV dysfunction.
Right Ventricular Dysfunction
Causes could be secondary to LV dysfunction, acute pulmonary embolism, RV infarction, severe tricuspid regurgitation [29], cor pulmonale secondary to lung disease, etc. TEE can evaluate RV size, function, and presence of RWMA and assess inter-ventricular septum position. Acute pressure/volume overload, RV ischemia, pulmonary embolism, worsening pulmonary hypertension, post-cardiopulmonary bypass complications, or chronic cor pulmonale. TEE views to evaluate RV function include mid-esophageal 4 chamber, trans-gastric SAX, and RV inflow-outflow view.
In patients with hemodynamic instability due to arrhythmias where the patient requires cardioversion, careful surveillance for thrombus in the LAA, LV apex, shunts, and right heart helps prevent thromboembolic phenomena [30].
Mechanical Circulatory Support
In-hospital cardiac arrests are emergencies requiring immediate differential diagnosis. TEE can play a critical role in managing patients during this time. It offers real-time imaging, allowing clinicians to assess cardiac function, identify potential causes of arrest, decrease duration of pulse check, and guide resuscitative efforts. TEE facilitates visualization of cardiac structures, assessment of ventricular wall motion, evaluation of valvular function, and detection of reversible causes such as cardiac tamponade or massive pulmonary embolism [13, 31]. Moreover, TEE optimizes chest compressions by providing immediate feedback on the effectiveness of cardiopulmonary resuscitation (CPR) and the return of spontaneous circulation (ROSC). This real-time imaging modality enhances diagnostic accuracy, aiding timely decision-making in the intense setting of cardiac arrest, ultimately contributing to improved patient outcomes. In peri-arrest situations, TEE also informs the need for MCS, guides the selection of the appropriate type of support, assists in their placement, prevents complications, evaluates therapy response post-placement and can also provide hemodynamic information needed during weaning of MCS [26, 31, 32].
-
LV and RV function
-
Valve function, particularly aortic regurgitation
-
Devices in the heart or prosthesis
-
Thrombus
-
Aorta dissection or calcification
-
Presence of ASD, PFO, VSD
Table 3 contains details on the types of temporary MCS devices and assessment using TEE.
Intra-Aortic Balloon Pump
The intra-aortic balloon pump (IABP) functions as a short term MCS device for cardiogenic shock, MI, ventricular dysfunction, high-risk PCI, unstable angina, and challenges post-cardiopulmonary bypass (Refer to Fig. 6). TEE enables the practitioner to evaluate the necessity for IABP, identify contraindications to placement, confirm proper position, and assess complications and hemodynamic response by examining LV and RV function (Refer to Table 3) [13, 31, 32]. Subsequent TEE monitoring gauges the therapeutic response, identifies complications and helps with weaning. An IABP is typically inserted via the femoral artery and infrequently via the axillary artery. It resides in the descending aorta which is seen in the SAX view of the aorta. To visualize its tip, the probe is pulled back and the position of the tip is marked on the probe. Further withdrawing the probe and turning it counterclockwise brings the left subclavian artery into view near the aortic arch. The distance between the tip and the left subclavian artery is measured and should ideally be 2–3 cm.
Temporary Left Ventricular Assist Device
A temporary left ventricular assist device (LVAD) is usually placed in the LV via the aorta for ventricular unloading (Refer to Fig. 7). Its use has significantly increased over the last several years. Typical indications include cardiogenic shock, high risk PCI, bridge to transplant and as an LV vent. Placement is usually from the femoral artery or axillary artery. For placement, the guidewire and catheter are first seen in the descending aorta (transfemoral approach). For its final positioning in the LV an ME LAX view is obtained. This view helps visualize the mitral valve, LV, LVOT, aortic valve and ascending aorta. The teardrop-shaped inlet should ideally be 3.5-4 cm from the aortic valve [13, 31, 32], outlet about 3 cm above the aortic valve (Refer to Table 3) The temporary LVAD should be free in the LV and not against the mitral valve apparatus; it is important to check for mitral regurgitation in the same view. The position of the septum should be midline and is evaluated in the ME four-chamber and LAX views. The P level and weaning can be determined based on the LV and RV function and septum position.
RV Assist Device Placement and Management
A temporary RV assist device is a double lumen cannula inserted via the right internal jugular vein into the right side with its tip residing in the pulmonary artery (Refer to Fig. 8) for RV failure or in refractory hypoxia. The device drains venous blood from the right atrium to an ECMO for oxygenation and is pumped back into the pulmonary artery [33]. The inflow cannula entering from the SVC can be seen in the mid-esophageal bicaval view (right side of the screen). Obtaining the RV inflow-outflow view helps to visualize the cannula traversing the right atrium, tricuspid valve, RV and pulmonic valve into its final position in the pulmonary artery. The tip of the outflow cannula is best seen by obtaining the ascending aorta short-axis view in the upper esophagus at 0° [13]. The tricuspid valve and interventricular septum position should be assessed, and the cannula should be repositioned or the pump speed adjusted based on echocardiographic findings.
Veno-Arterial Extracorporeal Membrane Oxygenation (VA ECMO)
VA ECMO provides temporary biventricular support for oxygenation and circulation, utilizing either central or peripheral cannulation strategies. Indications include refractory cardiogenic shock, high-risk PCI/cardiac procedures, refractory arrhythmias and as a bridge to transplant or LVAD [13, 31, 34]. Central cannulation involves venous cannula placement in the RA or SVC and IVC, visible in the bicaval view [35] as seen in Fig. 9. The central arterial cannula in the aortic arch or ascending aorta can be seen in the ascending aorta SAX view. Peripheral cannulation includes the venous cannula in the RA visualized in the bicaval view, and the peripheral arterial cannula in the descending aorta (femoral) or aortic arch (axillary). Continuous flow monitoring is crucial, with a comprehensive assessment post-placement for potential complications like dissection, hypoperfusion. In the case of LV distension, consider LV venting or decompression with IABP or temporary LVAD. Successful weaning predictors include LVEF > 20%, lateral mitral S’ velocity > 6cm/sec, aortic VTI > 10 cm, and increased lateral e’ and tricuspid annular S’ velocity [31, 36, 37].
ECMO-Cardiopulmonary Resuscitation (ECPR)
VA ECMO can be used as an adjunct to CPR during cardiac arrest to improve perfusion to organs and improve survival rates. ECPR is initiated emergently if ROSC is not achieved in younger, witnessed, reversible cardiac arrests within 10 min [38, 39]. TEE can be a key player in successful placement and initiation of bedside VA ECMO during these emergent situations. Unique advantages of TEE include visualization of guidewires in the aorta (for arterial cannula) and right atrium (for venous cannula), no interference with chest compressions and lack of radiation exposure.
Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO)
VV ECMO is used for patients whose oxygenation and ventilation are compromised despite appropriate mechanical ventilation and medical therapy. Extracorporeal Life Support Organization (ELSO) guidelines help provide direction on indications, maintenance and weaning of VV ECMO [34, 35] Venous blood can be drained from the SVC, IVC, RA or femoral vein. In single-site and two-site insertions, oxygenated blood is returned to the RA with its direction towards the tricuspid valve. This can be visualized on the TEE in the ME four-chamber view, RV inflow-outflow view, and modified bicaval view [13, 31, 35].
Hypoxemia Evaluation
While TEE has found its widest application in evaluating cardiac structures and for hemodynamic monitoring, it can also provide high quality images of other important structures, including the lungs, aorta and venous system. Figure 10 provides a comprehensive evaluation of TEE for hypoxemia which offers a unique opportunity to assess and alter our management with supportive findings.
Lung Ultrasound with TEE
Transesophageal lung ultrasound (TELU) is a novel technique increasingly being used to evaluate the pulmonary system. Though not validated, some of its findings can be inferred from transthoracic lung ultrasound (TTLU). The left lung is effectively visualized via the aorta, while visualization of the right lung poses difficulty due to proximity of the right side of the esophagus to vertebral bodies. Lack of an acoustic window from the scapula makes posterosuperior segments accessible only to TEE [2••, 39, 55].
Indications include hemodynamic instability, hypoxemia and routine evaluation if a TEE is already in place. Performing TELU during every TEE examination in the ICU will help advance our understanding in this evolving field.
Method
For lung parenchymal assessment, the left subclavian artery, left superior pulmonary vein and IVC-RA junction are identified at 0° which corresponds to apical, mid and basal levels respectively [40]. Please refer to Table 4 for additional details.
The omniplane is rotated to 90° and the probe is turned to each side to carefully examine anterior, lateral and basal segments at each level. Presence of A lines, B lines, air bronchograms and hepatization are important findings for our critically ill patients in the ICU which may alter our management [40, 41]. A-lines are reverberation artifacts of hyperechoic horizontal lines equidistant from the pleura at regular intervals [21, 42]. Their presence is diminished by B lines and enhanced by pneumothorax. B lines or comet tails are vertical reverberation artifacts arising from the pleural line. The presence of three or more indicates pulmonary edema or interstitial disease [42, 43]. Lung consolidation appears as liver-like areas of increased density called hepatization. Air bronchograms are hyperechoic foci in these consolidated areas [21, 39, 42]. Dynamic vs static air bronchograms help distinguish consolidation from atelectasis.
Pleura should also be assessed at all three levels. The near field of visceral pleura may be difficult to assess because of the phased array probe and the far field may be obscured due to artifacts. This makes non-tension pneumothorax difficult to diagnose on TELU. Lung sliding can be appreciated. In cardiac surgery, intraoperative TEE is commonly employed to detect the presence of pleural effusion with a 97% sensitivity and 100% specificity [40, 43]. Pleural effusions can be unilateral or bilateral and are qualitatively classified into simple and complex, depending on their echogenicity [36]. Please refer to Figs. 11 and 12.
Capper’s method for quantification of pleural effusion.
Pleural fluid volume = Maximal cross-sectional area (CSA) x axial length (AL).
This correlated well with actual volume of pleural effusion [40, 44]. CSA is measured by tracing the maximal surface area and AL is determined from the craniocaudal length by manually advancing the probe.
Veins
Standard views on TEE are used to analyze the SVC, IVC, hepatic vein, coronary sinus and pulmonary veins. Thrombosis, stenosis, and fluid overload can be diagnosed. Thrombosis is of particular concern, especially among our critically ill ICU patients as discussed earlier, leading to a risk of pulmonary embolism. All the veins must be evaluated with and without color, and pulsed wave Doppler signals should be obtained whenever alignment is possible. Flow should be antegrade and S and D waves above the baseline are considered normal (As seen in Fig. 13). SVC and IVC are best seen in the bicaval view, and the hepatic vein is best seen by advancing the probe into the stomach from the bicaval view and decreasing the omniplane. Obtaining these views in conjunction with the RV inflow-outflow view and ascending aorta SAX view can be extremely helpful for pulmonary artery catheter placement, especially in patients with mechanical circulatory devices where pressure tracings may not be discernible.
The venous excess ultrasound score or VExUS was developed as a prognostic tool for acute kidney injury, but is being increasingly used to guide fluid management [45]. IVC, hepatic vein, portal vein and renal vein need to be assessed for determining the score. IVC is assessed in the SAX view and a diameter of > 2 cm and collapsibility of < 50% is considered abnormal (Refer to Fig. 14). After obtaining the hepatic vein view, the probe is advanced and the thick, echo-dense portal vein can be seen in the liver parenchyma. At times the left renal vein may be visualized by rotating the probe to the left in the stomach at a multiplane angle of 90° [20].
There are several limitations to the above method. Mechanical ventilation, IVC stents, cannulas in the IVC, tricuspid regurgitation, and increased intra-abdominal and intrathoracic pressures make IVC collapsibility inaccurate. Intrarenal vein flow is difficult to visualize, and portal vein flow measurements may be questionable due to challenges with alignment. Relying mainly on IVC diameter and hepatic vein flow will simplify VExUS grading and provide a good picture of volume status [46, 47] (Refer to Fig. 15)
Heart
Cardiac causes of hypoxemia are most commonly due to shunts or thromboembolic phenomenon. The TEE calculation of Qp:Qs, or the ratio of pulmonary to systemic blood flow helps diagnose and quantify intracardiac or extracardiac shunts. By comparing the flow through the pulmonary circulation (Qp) to the flow through the systemic circulation (Qs), clinicians can determine if there is a shunt, its direction (left-to-right or right-to-left), and the degree of shunting. Imaging of the interatrial septum, interventricular septum, pulmonary veins and coronary sinus can reveal shunts and congenital causes of hypoxia.
It is crucial to look for the presence of pulmonary embolism in the ascending aorta SAX view in hypoxic and hemodynamically unstable patients. It increases morbidity and mortality significantly [2••, 48]. Careful imaging of IVC, SVC, RA and RV for thrombus if PE is suspected is a crucial step. The presence of right-sided valvular vegetations [49, 50] are a supportive finding for chronic pulmonary thromboembolism.
Recent Developments
TEE as an imaging modality has greatly advanced since its advent in 1976 [51]. Three-dimensional imaging has been around for more than a decade but faster image processing, improved frame rates, and automated analysis have decreased imaging time and greatly improved accuracy [52]. Smaller probes with 2D, 3D, 4D, color and Doppler capabilities are being launched. Efforts are being made to integrate artificial intelligence to automate functions, improve valve assessments, volume quantification and optimize structural heart evaluations [52, 53•, 54]. Automated volume measurements, speckle and strain tracking are some unique and exciting offerings that are anticipated to further enhance TEE's role in critical care [7, 53, 54].
Conclusion
TEE is a versatile diagnostic tool offering a comprehensive assessment of cardiac function in critically ill patients. While less common than TTE in the ICU, TEE is particularly valuable in scenarios such as mechanical ventilation, prone positioning, and when there are challenges with TTE windows due to body habitus or surgical dressings. Ongoing education and competence assessment for providers is crucial for optimal utilization and to prevent complications.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Guevarra K, Greenstein Y. Ultrasonography in the Critical Care Unit. Curr Cardiol Rep. 2020;22(11):145 PMID: 32910332; PMCID: PMC7481757.
•• Lau YH, See KC. Point-of-care ultrasound for critically-ill patients: A mini-review of key diagnostic features and protocols. World J Crit Care Med. 2022;11(2):70–84 PMID: 35433316; PMCID: PMC8968483. The review integrates cardiac, lung, and abdominal ultrasound and focuses on POCUS protocols.
Hauser ND, Swanevelder J. Transoesophageal echocardiography (TOE): contra-indications complications and safety of perioperative TOE. Echo Res Pract. 2018;5(4):R101–13 PMID: 30303686; PMCID: PMC6144934.
Khoury AF, Afridi I, Quiñones MA, Zoghbi WA. Transesophageal echocardiography in critically ill patients: feasibility, safety, and impact on management. Am Heart J. 1994;127(5):1363–71.
Daniel WGA. Mügge Transesophageal echocardiography. N Engl J Med. 1995;332(19):1268–79.
O’Rourke MC, Goldstein S, Mendenhall BR. Transesophageal Echocardiogram. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK442026/
Hüttemann E. Transoesophageal echocardiography in critical care. Minerva Anestesiol. 2006;72(11):891–913 PMID: 17095988.
Hilberath JN, Oakes DA, Shernan SK, Bulwer BE, D’Ambra MN, Eltzschig HK. Safety of transesophageal echocardiography. J Am Soc Echocardiogr. 2010;23(11):1115–27.
Szyszka A, Płońska-Gościniak E. Transesophageal echocardiography. J Ultrason. 2019;19(76):62–5 PMID: 31088013; PMCID: PMC6750177.
Herbold T, Chon SH, Grimminger P, Maus MKH, Schmidt H, Fuchs H, Brinkmann S, Bludau M, Gutschow C, Schröder W, Hölscher AH, Leers JM. Endoscopic Treatment of Transesophageal Echocardiography-Induced Esophageal Perforation. J Laparoendosc Adv Surg Tech A. 2018;28(4):422–8 Epub 2018 Jan 12 PMID: 29327976.
Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland GR, Grube E, Hanrath P, Maisch B, Dennig K. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circ. 1991;83(3):817–21.
• Kirkpatrick JN, Grimm R, Johri AM, Kimura BJ, Kort S, Labovitz AJ, Lanspa M, Phillip S, Raza S, Thorson K, Turner J. Recommendations for echocardiography laboratories participating in cardiac point of care cardiac ultrasound (POCUS) and critical care echocardiography training: report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2020;33(4):409–22. This article talks about the training required for critical care ultrasound examination and expanding the ultrasound exam beyond cardiac ultrasound.
Nicoara A, Skubas N, Ad N, Finley A, Hahn RT, Mahmood F, Mankad S, Nyman CB, Pagani F, Porter TR, Rehfeldt K, Stone M, Taylor B, Vegas A, Zimmerman KG, Zoghbi WA, Swaminathan M. Guidelines for the Use of Transesophageal Echocardiography to Assist with Surgical Decision-Making in the Operating Room: A Surgery-Based Approach: From the American Society of Echocardiography in Collaboration with the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons. J Am Soc Echocardiogr. 2020;33(6):692–734 Erratum in: J Am Soc Echocardiogr. 2020 Nov;33(11):1426. PMID: 32503709.
Pinsky MR. Functional hemodynamic monitoring. Crit Care Clin. 2015;31(1):89–111 PMID: 25435480; PMCID: PMC4250574.
Denault A, Vegas A, Royse C. Bedside clinical and ultrasound-based approaches to the management of hemodynamic instability–part I: focus on the clinical approach: continuing professional development. Can J Anaesth. 2014;61(9):843–64 English, French. Epub 2014 Aug 29. PMID: 25169906.
Vegas A, Denault A, Royse C. A bedside clinical and ultrasound-based approach to hemodynamic instability - Part II: bedside ultrasound in hemodynamic shock: continuing professional development. Can J Anaesth. 2014;61(11):1008–27 Epub 2014 Oct 2 PMID: 25274122.
Reeves ST, Finley AC, Skubas NJ, Swaminathan M, Whitley WS, Glas KE, Hahn RT, Shanewise JS, Adams MS, Council on Perioperative Echocardiography of the American Society of Echocardiography, Society of Cardiovascular Anesthesiologists. Shernan SK Basic perioperative transesophageal echocardiography examination: a consensus statement of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26(5):443–56 PMID: 23622926.
Slama M, Maizel J. Assessment of fluid requirements: fluid responsiveness. In: Hemodynamic monitoring using echocardiography in the critically ill. Springer, Berlin Heidelberg: Berlin, Heidelberg; 2010. p. 61–9.
Slama M, Masson H, Teboul JL, Arnout ML, Susic D, Frohlich E, Andrejak M. Respiratory variations of aortic VTI: a new index of hypovolemia and fluid responsiveness. American Journal of Physiology-Heart and Circulatory Physiology. 2002;283(4):H1729–33.
Beaubien-Souligny W, Denault AY. Real-Time Assessment of Renal Venous Flow by Transesophageal Echography During Cardiac Surgery. A & A Pract. 2019;12(1):30–2.
Bhoil R, Ahluwalia A, Chopra R, Surya M, Bhoil S. Signs and lines in lung ultrasound. J Ultrason. 2021;21(86):e225–33 Epub 2021 Sep 9. PMID: 34540277; PMCID: PMC8439137.
Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, Reeves ST, Shanewise JS, Siu SC, Stewart W, Picard MH. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26(9):921–64 PMID: 23998692.
Hulin J, Aslanian P, Desjardins G, Belaïdi M, Denault A. The Critical Importance of Hepatic Venous Blood Flow Doppler Assessment for Patients in Shock. A A Case Rep. 2016;6(5):114–20 PMID: 26556108.
Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol. 1990;66(4):493–6.
Sidebotham D. Practical perioperative transesophageal echocardiography: with critical care echocardiography clinical key. 2012.
Joseph MX, Disney PJ, Da Costa R, Hutchison SJ. Transthoracic echocardiography to identify or exclude cardiac cause of shock. Chest. 2004;126(5):1592–7 PMID: 15539732.
Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock J Am Heart Assoc. 2019;8(8):e011991.
Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med. 1994;330(24):1724–30.
Mulla S, Asuka E, Bora V, Siddiqui WJ. Tricuspid Regurgitation. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2023. PMID: 30252377
Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol. 1995;25(6):1354–61 PMID: 7722133.
Del Rio J, Milano CA, Nicoara A. Assessment of Mechanical Circulatory Support Devices. In: Mathew JP, Nicoara A, Ayoub CM, Swaminathan M. eds. Clinical Manual and Review of Transesophageal Echocardiography, 3e. McGraw Hill; 2018.
Anand S, Barry T, Arsanjani R, LeMond L. Echocardiography in Cardiac Assist Devices. Rev Cardiovasc Med. 2022;23(7):253.
Successful use of Protek Duo cannula to provide veno-venous extra-corporeal membrane oxygenation and right ventricular support for acute respiratory distress syndrome in an adolescent with complex congenital heart disease. Perfusion. 2021;36(2):200–203.
Gajkowski EF, Herrera G, Hatton L, Velia Antonini M, Vercaemst L, Cooley E. ELSO Guidelines for Adult and Pediatric Extracorporeal Membrane Oxygenation Circuits. ASAIO J. 2022;68(2):133–52 Erratum in: ASAIO J. 2022 Jul 1;68(7):e131. PMID: 35089258.
Mazzeffi MA, Rao VK, Dodd-O J, Del Rio JM, Hernandez A, Chung M, Bardia A, Bauer RM, Meltzer JS, Satyapriya S, Rector R, Ramsay JG, Gutsche J. Intraoperative Management of Adult Patients on Extracorporeal Membrane Oxygenation: An Expert Consensus Statement From the Society of Cardiovascular Anesthesiologists-Part I, Technical Aspects of Extracorporeal Membrane Oxygenation. Anesth Analg. 2021;133(6):1459–77 PMID: 34559089.
Kim D, Jang WJ, Park TK, Cho YH, Choi JO, Jeon ES, Yang JH. Echocardiographic Predictors of Successful Extracorporeal Membrane Oxygenation Weaning After Refractory Cardiogenic Shock. J Am Soc Echocardiogr. 2021;34(4):414-422.e4 Epub 2020 Dec 13 PMID: 33321165.
Aissaoui N, Luyt CE, Leprince P, Trouillet JL, Léger P, Pavie A, Diebold B, Chastre J, Combes A. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med. 2011;37(11):1738–45 Epub 2011 Oct 1 PMID: 21965097.
Kumar KM. ECPR-extracorporeal cardiopulmonary resuscitation. Indian J Thorac Cardiovasc Surg. 2021;37(Suppl 2):294–302 Epub 2021 Jan 7. PMID: 33432257; PMCID: PMC7787697.
Abrams D, MacLaren G, Lorusso R, Price S, Yannopoulos D, Vercaemst L, Bělohlávek J, Taccone FS, Aissaoui N, Shekar K, Garan AR, Uriel N, Tonna JE, Jung JS, Takeda K, Chen YS, Slutsky AS, Combes A, Brodie D. Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications. Intensive Care Med. 2022;48(1):1–15 Epub 2021 Sep 10. PMID: 34505911; PMCID: PMC8429884.
Cavayas YA, Girard M, Desjardins G, et al. Transesophageal lung ultrasonography: a novel technique for investigating hypoxemia. Can J Anesth/J Can Anesth. 2016;63:1266–76. https://doi.org/10.1007/s12630-016-0702-2.
Weber AG, Mastroianni F, Koenig S, Mayo PH. Transesophageal Lung Ultrasonography as Part of the Critical Care Transesophageal. Echocardiography Examination, Chest. 2022;161(6):e335–6.
Neto Francisco MJ. Rahal A Junior, Vieira FA, Silva PS, Funari MB. Advances in lung ultrasound Einstein (Sao Paulo). 2016;14(3):443–8 PMID: 27759836; PMCID: PMC5234763.
Tsubo T, Yatsu Y, Okawa H, Ishihara H, Matsuki A. Transesophageal echocardiography is a sensitive method to evaluate pleural effusion. Anesthesiology. 2002;96:A322.
Capper SJ, Ross JJ, Sandström E, Braidley PC, Morgan-Hughes NJ. Transoesophageal echocardiography for the detection and quantification of pleural fluid in cardiac surgical patients. Br J Anaesth. 2007;98(4):442–6. https://doi.org/10.1093/bja/aem010. Epub 2007 Mar 8 PMID: 17347183.
Singh K, Carvalho R. Perioperative Venous Excess Ultrasound Score (VExUS) to Guide Decongestion in a Dilated Cardiomyopathy Patient Presenting for Urgent Surgery. Cureus. 2021;13(12).
Rola P, Miralles-Aguiar F, Argaiz E, et al. Clinical applications of the venous excess ultrasound (VExUS) score: conceptual review and case series. Ultrasound J. 2021;13:32. https://doi.org/10.1186/s13089-021-00232-8.
Singh NG, Kumar KN, Nagaraja PS, Manjunatha N. Portal venous pulsatility fraction, a novel transesophageal echocardiographic marker for right ventricular dysfunction in cardiac surgical patients. Ann Card Anaesth. 2020;23(1):39–42 PMID: 31929245; PMCID: PMC7034200.
Volpicelli G, Mayo P, Rovida S. Focus on ultrasound in intensive care. Intensive Care Med. 2020;46:1258–60. https://doi.org/10.1007/s00134-020-06027-0.
MacKay EJ, Neuman MD, Fleisher LA, Patel PA, Gutsche JT, Augoustides JG, Desai ND, Groeneveld PW. Transesophageal Echocardiography, Mortality, and Length of Hospitalization after Cardiac Valve Surgery. J Am Soc Echocardiogr. 2020;33(6):756-762.e1 Epub 2020 Mar 26. PMID: 32222480; PMCID: PMC7276287.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, Anderson JL, Halperin JL, Albert NM, Bozkur B, Brindis RG, Creager MA, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Stevenson WG, Yancy CW, American College of Cardiology, American College of Cardiology/American Heart Association, American Heart Association. 2014AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–132. https://doi.org/10.1016/j.jtcvs.2014.05.014.
Orihashi K. The history of transesophageal echocardiography: the role of inspiration, innovation, and applications. J Anesth. 2020;34(1):86–94 Epub 2019 Nov 8 PMID: 31705328.
Wang CL, Hung KC. Recent Advances in Echocardiography. J Med Ultrasound. 2017;25(2):65–7 Epub 2017 May 9. PMID: 30065461; PMCID: PMC6029319.
• Mielnicki W, Dyla A, Małyszek-Tumidajewicz J. A systematic approach to transoesophageal echocardiography in the intensive care unit - a practical guide for intensivists. Anaesthesiol Intensive Ther. 2021;53(4):329–35 PMID: 35257566; PMCID: PMC10165990. The review provides details of the therapeutic and diagnostic impact of transesophageal echocardiography in the ICU and emphasizes on a systematic approach to TEE in critical care.
Garcia YA, Quintero L, Singh K, Lakticova V, Iakovou A, Koenig SJ, Narasimhan M, Mayo PH. Feasibility, safety, and utility of advanced critical care transesophageal echocardiography performed by pulmonary/critical care fellows in a medical ICU. Chest. 2017;152(4):736–41.
Bouhemad B, Mongodi S, Via G. Isabelle Rouquette; Ultrasound for “Lung Monitoring” of Ventilated Patients. Anesthesiology. 2015;122:437–47.
Author information
Authors and Affiliations
Contributions
Dr. Bora and Dr. Pulijal contributed to reviewing literature available for the article and drafting it in detail. We also acquired images using transesophageal echocardiography for the manuscript and prepared tables.
Corresponding author
Ethics declarations
Conflicts of Interest
Dr. Vaibhav Bora declares that he has no conflicts of interest. Dr. Sri Varsha Pulijal declares that she has no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors. All tables and figures are original.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bora, V., Pulijal, S.V. Transesophageal Echocardiography in Critical Care. Curr Pulmonol Rep 13, 152–172 (2024). https://doi.org/10.1007/s13665-024-00351-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13665-024-00351-2